3.0
23 Mar 2024
Current employee, more than 10 years
Risch, Zug
Recommend
CEO approval
Business outlook
Pros
-Facilities -Social responsibility -Pharma giant
Cons
-Nepotism -Politics over fair evaluation -Constant restructuring the last 5 years -80% women in new managerial positions without fair evaluation or having experience -Germans hire Germans (not even Swiss are given a fair chance)